Endothelin receptor antagonists exhibit diminishing potency following incubation with agonist
- 31 December 1994
- journal article
- Published by Elsevier in Life Sciences
- Vol. 54 (22) , 1727-1734
- https://doi.org/10.1016/0024-3205(94)00613-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonistNature, 1993
- Design of a functional hexapeptide antagonist of endothelinJournal of Medicinal Chemistry, 1992
- A reversible radioligand specific for the ETB receptor: [125I]Tyr13-Suc-[Glu9,Ala11,15]-endothelin-1(8–21), [125I]IRL 1620Biochemical and Biophysical Research Communications, 1992
- A novel radioligand [125I]BQ-3020 selective for endothelin (ETB) receptorsLife Sciences, 1992
- An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensisBiochemical and Biophysical Research Communications, 1991
- Identification of a Single Binding Protein for Endothelin-1 and Endothelin-3 in Bovine Cerebellum MembranesEndocrinology, 1991
- Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 1990
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990
- Purification of an endothelin receptor from human placentaBiochemical and Biophysical Research Communications, 1990
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988